BCM
BIOA

Bridgeway Capital Management’s BioAge Labs BIOA Stock Holding History

Bridgeway Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Sell
57,600
-20,000
-26% -$385K 0.02% 704
2025
Q4 		$1.03M Buy
77,600
+25,000
+48% +$222K 0.02% 698
2025
Q3 		$309K Hold
52,600
– – 0.01% 919
2025
Q2 		$217K Buy
+52,600
New +$212K 0.01% 944

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bridgeway Capital Management's BIOA Position: Q1 2026 in Review

Bridgeway Capital Management reduced its BioAge Labs (BIOA) stake by 26% in Q1 2026, selling an estimated $385K and leaving 57,600 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #704.

Bridgeway Capital Management first reported a position in BIOA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.03M in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Bridgeway Capital Management held 57,600 shares of BioAge Labs worth $1.01M as of Q1 2026.
  • Bridgeway Capital Management sold 20,000 BioAge Labs shares in Q1 2026, an estimated $385K.
  • BioAge Labs made up 0.02% of Bridgeway Capital Management's portfolio in Q1 2026, its #704 holding.
  • Bridgeway Capital Management first reported a position in BioAge Labs in Q2 2025 and has held it in 4 quarters since.
  • Bridgeway Capital Management's BioAge Labs position peaked at $1.03M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.